📣 VC round data is live. Check it out!

Cardinal Health Valuation Multiples

Discover Cardinal Health's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Ferguson, Fastenal, Cencora, Sumitomo and more.

Cardinal Health Overview

About Cardinal Health

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.


Founded

1979

HQ

United States

Employees

57.7K

Financials (LTM)

Revenue: $253B
EBITDA: $4B

EV

$51B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cardinal Health Financials

Cardinal Health reported last 12-month revenue of $253B and EBITDA of $4B.

In the same LTM period, Cardinal Health generated $10B in gross profit, $4B in EBITDA, and $3B in net income.

Revenue (LTM)


Cardinal Health P&L

In the most recent fiscal year, Cardinal Health reported revenue of $223B and EBITDA of $3B.

Cardinal Health is profitable as of last fiscal year, with gross margin of 4%, EBITDA margin of 1%, and net margin of 1%.

See analyst estimates for Cardinal Health
LTMLast FY202320242025202620272028
Revenue$253B$223B$216B$225B$239B
Gross Profit$10B$8B$7B$8B$9B
Gross Margin4%4%3%3%4%
EBITDA$4B$3B$2B$3B$4B
EBITDA Margin2%1%1%1%1%
EBIT Margin1%1%1%1%1%
Net Profit$3B$2B$557M$1B$2B
Net Margin1%1%0%1%1%
Net Debt-$5B---

Financial data powered by Morningstar, Inc.

Cardinal Health Stock Performance

Cardinal Health has current market cap of $46B, and enterprise value of $51B.

Market Cap Evolution


Cardinal Health's stock price is $195.15.

Cardinal Health share price decreased by 0.8% in the last 30 days, and increased by 16.2% in the last year.

Cardinal Health has an EPS (earnings per share) of $8.52.

See more trading valuation data for Cardinal Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$51B$46B-0.8%-0.8%-7.6%16.2%$8.52

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cardinal Health Valuation Multiples

Cardinal Health trades at 0.2x EV/Revenue multiple, and 12.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Cardinal Health

EV / Revenue (LTM)


Cardinal Health Financial Valuation Multiples

As of June 2, 2026, Cardinal Health has market cap of $46B and EV of $51B.

Cardinal Health has a P/E ratio of 18.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.2x0.2x0.2x0.2x0.2x
EV/EBITDA12.8x15.9x29.9x20.0x14.2x
EV/EBIT14.7x18.2x26.0x22.8x17.4x
EV/Gross Profit5.1x6.2x7.1x6.5x5.6x
P/E18.2x22.9x82.1x37.9x22.3x
EV/FCF15.8x20.5x18.1x19.9x19.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cardinal Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cardinal Health Margins & Growth Rates

Cardinal Health grew revenue by 15% and EBITDA by 26% in the last fiscal year.

In the most recent fiscal year, Cardinal Health reported gross margin of 4%, EBITDA margin of 1%, and net margin of 1%.

See estimated margins and future growth rates for Cardinal Health

Cardinal Health Margins

Last FY202420252026202720282029
Gross Margin4%3%4%4%
EBITDA Margin1%1%1%2%
EBIT Margin1%1%1%1%
Net Margin1%1%1%1%
FCF Margin1%1%1%1%

Cardinal Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth15%4%7%11%
Gross Profit Growth23%9%17%28%
EBITDA Growth26%50%41%19%
EBIT Growth26%14%31%27%
Net Profit Growth28%117%70%30%
FCF Growth33%(9%)1%31%

Data powered by FactSet, Inc. and Morningstar, Inc.

Cardinal Health Operational KPIs

Cardinal Health's revenue per employee in the last FY averaged $3.9M, while opex per employee averaged $0.1M for the same period.

Cardinal Health's Rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cardinal Health's Rule of X is 30% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cardinal Health
LTMLast FY202320242025202620272028
Rule of 4010%13%---
Bessemer Rule of X23%30%---
Revenue per Employee-$3.9M---
Opex per Employee-$0.1M---
Opex to Revenue-3%2%2%2%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cardinal Health Competitors

Cardinal Health competitors include Ferguson, Fastenal, Cencora, Sumitomo, Sysco, Grainger, Bunge, Rheinmetall, US Foods and Bollore.

Most Cardinal Health public comparables operate across Wholesale Distribution.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ferguson1.6x1.5x16.3x15.5x
Fastenal6.2x5.9x27.5x26.3x
Cencora0.2x0.2x13.1x12.1x
Sumitomo1.6x1.5x11.3x17.4x
Sysco0.6x0.6x11.3x11.1x
Grainger3.4x3.3x20.6x19.5x
Bunge0.6x0.5x14.9x12.6x
Rheinmetall6.0x5.1x26.5x22.5x

This data is available for Pro users. Sign up to see all Cardinal Health competitors and their valuation data.

Start Free Trial

Acquisitions by Cardinal Health

Cardinal Health has acquired 18 companies to date.

Last acquisition by Cardinal Health was on August 12th 2025. Cardinal Health acquired Solaris Health for $2B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Cardinal Health

Solaris Health
GI Alliance
Advanced Diabetes Supply
Integrated Oncology Network
Description
Solaris Health is a healthcare consulting firm that delivers operational optimization, patient engagement solutions, and data analytics services to providers. Based in the United States, the company partners with hospitals and clinics to implement efficiency strategies, clinical decision tools, and technology integrations for improved care delivery and outcomes.
GI Alliance is a Dallas-headquartered physician-led network of gastroenterology practices across the United States. It unites over 600 providers in more than 350 locations, focusing on advanced endoscopic procedures, clinical research, and patient-centered care in digestive health.
Advanced Diabetes Supply is a national distributor of durable medical equipment focused on diabetes management products like glucose monitors, test strips, and insulin pumps. The company holds NABP, URAC, and ACHC accreditations, ensuring compliance in mail-order and non-mail-order supplies. Operating from Twinsburg, Ohio, it prioritizes rapid delivery and customer support for patients across the United States.
Integrated Oncology Network is a nationwide oncology practice management organization headquartered in Newport Beach, California. The firm offers operational, financial, and strategic advisory services to cancer centers, hospitals, radiation oncology groups, and physician practices throughout the United States. ION manages over 30 oncology practices with services encompassing revenue cycle management, compliance, EHR implementation, and payer contracting for providers affiliated with networks like Sarah Cannon Cancer Institute.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Fort Lauderdale, FL
Dallas, TX
San Diego, CA
Los Angeles, CA
Deal Date12 Aug 202511 Nov 202411 Nov 202420 Sep 2024
Valuation$2B$4B$1B$1B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cardinal Health acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Cardinal Health

Cardinal Health has invested in 7 companies to date.

Latest investment by Cardinal Health was on December 16th 2025. Cardinal Health invested in Ember LifeSciences in their $17M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Cardinal Health

Ember LifeSciences
RxLive
Medically Home
Vineti
Description
Ember LifeSciences is a healthcare logistics firm offering self-refrigerated, cloud-connected containers like the Ember Cube for transporting temperature-sensitive pharmaceuticals, vaccines, and biologics with real-time monitoring.
RxLive is a telehealth platform staffed by clinical pharmacists who deliver medication management services across the United States. It provides virtual consultations, therapy optimization, and deprescribing recommendations to improve patient outcomes in polypharmacy cases and chronic disease management.
Medically Home is a Boston-headquartered provider of hospital-at-home services that equips health systems to deliver acute care directly in patients' residences. Its technology platform facilitates remote patient monitoring, clinician coordination, and access to a centralized command center for high-acuity conditions such as heart failure and COPD exacerbations. Launched in 2016, the company partners with leading institutions including Mayo Clinic, Cleveland Clinic, and UPMC to administer thousands of home-based hospital episodes across states like Tennessee, Texas, and Minnesota. Medically Home integrates telehealth, mobile diagnostic units, and pharmacy fulfillment to replicate inpatient capabilities outside traditional facilities, supporting Medicare-covered programs nationwide.
Vineti is a San Francisco-headquartered provider of the Personalized Therapy Management platform for cell and gene therapy supply chains. Launched in 2016, its cloud-based software automates patient journeys for CAR-T treatments targeting leukemias and lymphomas. The platform tracks therapies from manufacturing sites in Boston to clinics in Houston, ensuring regulatory compliance for FDA approvals. Vineti serves pharmaceutical companies commercializing therapies like Kymriah from Novartis and Yescarta from Gilead across clinical trials and global distribution.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
-
St. Petersburg, FL
Boston, MA
San Francisco, CA
Deal Date16 Dec 202526 Jul 202210 Jan 202213 Oct 2020
RoundSeries ASeries AUndisclosed stageSeries C
Raised$17M$5M$110M$33M
InvestorsCardinal Health; Carrier Ventures; Michael Pompeo; Sea Court CapitalCardinal Health; Springtide VenturesBaxter International; Cardinal Health; Global Medical Response; Kaiser Permanente; Mayo Clinic; Wormhole CapitalCanaan Partners; Cardinal Health; Casdin Capital; Lifeforce Capital; Marc Benioff; McKesson Ventures; Novartis Pharma; S32; Threshold
Valuationundisclosedundisclosed$4Bundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cardinal Health investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cardinal Health

When was Cardinal Health founded?Cardinal Health was founded in 1979.
Where is Cardinal Health headquartered?Cardinal Health is headquartered in United States.
How many employees does Cardinal Health have?As of today, Cardinal Health has over 57K employees.
Who is the CEO of Cardinal Health?Cardinal Health's CEO is Jason M. Hollar.
Is Cardinal Health publicly listed?Yes, Cardinal Health is a public company listed on NYSE.
What is the stock symbol of Cardinal Health?Cardinal Health trades under CAH ticker.
When did Cardinal Health go public?Cardinal Health went public in 1983.
Who are competitors of Cardinal Health?Cardinal Health main competitors include Ferguson, Fastenal, Cencora, Sumitomo, Sysco, Grainger, Bunge, Rheinmetall, US Foods, Bollore.
What is the current market cap of Cardinal Health?Cardinal Health's current market cap is $46B.
What is the current revenue of Cardinal Health?Cardinal Health's last 12 months revenue is $253B.
What is the current revenue growth of Cardinal Health?Cardinal Health revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of Cardinal Health?Current revenue multiple of Cardinal Health is 0.2x.
What is the current EBITDA of Cardinal Health?Cardinal Health's last 12 months EBITDA is $4B.
What is Cardinal Health's EBITDA margin?Cardinal Health's last 12 months EBITDA margin is 2%.
What is the current EV/EBITDA multiple of Cardinal Health?Current EBITDA multiple of Cardinal Health is 12.8x.
What is the current FCF of Cardinal Health?Cardinal Health's last 12 months FCF is $3B.
What is Cardinal Health's FCF margin?Cardinal Health's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Cardinal Health?Current FCF multiple of Cardinal Health is 15.8x.
How many companies Cardinal Health has acquired to date?As of June 2026, Cardinal Health has acquired 18 companies.
What was the largest acquisition by Cardinal Health?$6B acquisition of Medtronic (patient monitoring & recovery unit) on 18th April 2017 was the largest M&A Cardinal Health has done to date.
What companies Cardinal Health acquired?Cardinal Health acquired Medtronic (patient monitoring & recovery unit), GI Alliance, Cordis, Solaris Health, Specialty Networks, Integrated Oncology Network, Advanced Diabetes Supply, The Harvard Drug Group, NaviHealth, Access Closure, and 8 other companies.
In how many companies Cardinal Health has invested to date?As of June 2026, Cardinal Health has invested in 7 companies.
What was the last Cardinal Health investment?On 16th December 2025 Cardinal Health invested in Ember LifeSciences, participating in a $17M Series A round, alongside Carrier Ventures, Michael Pompeo, and Sea Court Capital.
In what companies Cardinal Health invested in?Cardinal Health invested in Medically Home, Vineti, Ember LifeSciences, KEW Group, Enlace Health, HealthSpot, and RxLive.

See public comps similar to Cardinal Health

Lists including Cardinal Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial